3 New Strong Buy Ratings from Top-Rated Analysts: 01/31/2025

Smarter investing ideas, delivered. We scoured WallStreetZen’s Strong Buy Stocks from Wall Street’s Top Analysts feature for some of the most promising Strong Buy ratings — your sampling is below.

Intuitive Surgical Inc. (NASDAQ: ISRG) gets a price target increase after a great earnings report. Integer Holdings (NYSE: ITGR) is an appealing pick for risk-averse investors. Dolby Laboratories (NYSE: DLB) has a long — and potentially profitable — runway for growth. 

Gain access to dozens of alerts like this per week 👉👉 Try WallStreetZen Premium for just $1

1- Intuitive Surgical Inc. (NASDAQ: ISRG) 

This company makes robotic devices that help doctors perform surgeries. The stock has gained 57% in the past year thanks to a recent history of earnings beats and robust procedures; following its most recent earnings beat, the stock dropped but analysts remain optimistic. Here’s why we’re watching… 

Zen Rating: B (Buy) — see full analysis >  

Recent Price:  $582.82 — get current quote > 

Max 1-year forecast: $711.00 

Why we’re watching:

• Resounding Strong Buy consensus: Among the 13 analysts we track issuing ratings on ISRG, 9 of them rate it a Strong Buy. See the ratings
• Richard Newitter of Truist Securities (a top 5% analyst), for instance, recently raised their price target on ISRG by 4.1% from $640 to $666 following the company’s most recent earnings report. 
• The company's earnings beat was huge and its guidance for FY 2025 was "conservative," Newitter said, noting that the launch of the da Vinci 5 systems is "just getting going." 
• In addition, the analyst said Truist Securities' 9% EPS growth and 13% revenue growth forecasts were preliminary estimates that leave substantial potential for improvement.
• WallStreetZen gives ISRG’s industry (Medical) an overall A, indicating it’s a market niche with strong potential; with an overall Zen Rating of B (Buy), ISRG shines as being among the top 20% of all stocks we track. (Find out more and dig into each of the 7 Zen Component Grades here >)

A message from our sponsors...

Trump: "Steel Will Be the Backbone of the Country"

President Trump has declared steel the backbone of America's future, and one tiny East Coast company is already leading the charge.

With access to an unlimited supply of steel, this company has become a key player. Insiders and hedge funds are snapping up shares in anticipation of the Trump Superboom.

As demand for American steel skyrockets, this little-known stock could be positioned for massive gains.

Want the full name and ticker symbol? Click here.

Thanks to our sponsors for keeping this content free.

2- Integer Holdings (NYSE: ITGR) 

Analysts love ITGR stock. This medical device company, which specializes in cardiology-related products (think: cardiac monitors, pacemakers, etc), has enjoyed impressive growth in recent years — and signs point to continued momentum without excess volatility. 

Zen Rating: B (Buy)  — see full analysis >  

Recent Price: $144.77 — get current quote > 

Max 1-year forecast: $163.00 

Why we’re watching:

• 6 analysts we track rate ITGR a Strong Buy, and even the average 1-year forecast suggests upside in the coming year. See the ratings
• Among the analysts issuing Strong Buy ratings, Brett Fishbin of KeyBanc is particularly bullish. They just upped their 1-year price target on ITGR by 6.9% from $144 to $154 on 1/24, in advance of the company’s expected earnings on 2/20.  
• Fishbin contextualized their price target increase by saying that "the backdrop around relevant procedural areas appears healthy into the print and FY 2025, and the company continues to have solid near-term visibility into customer ordering patterns."
• ITGR has an overall Zen Rating of B (Buy). Not only is it in the top tier of all Medical Device stocks we track, but it’s in the top 20% overall of the 4600 stocks we track. 
• Looking at the Component Grades that make up the overall grade, ITGR has particular strength in two areas. It’s in the top 20% of stocks we track for Sentiment, which considers factors like earnings surprises, insider action, and the fluidity of analyst ratings. More impressively for risk-averse investors, it’s in the 94th percentile of stocks we track for Safety, indicating it may be a solid low-volatility stock. (See all 7 Zen Component Grades here >)

3- Dolby Laboratories (NYSE: DLB) 

No doubt you recognize the famous Dolby brand which has been enhancing sound for all forms of movie and TV entertainment over the years. The healthy foundation of that software business is just one of the many reasons to like DLB right now. 

Zen Rating:  A (Strong Buy) — see full analysis >  

Recent Price: $89.42 — get current quote > 

Max 1-year forecast: $100.00 

Why we’re watching:

• While only 2 analysts we track currently rate DLB, they’re both bullish: DLB has one Buy and one Strong Buy rating. See the ratings 
• Our resident stock-picking expert, Steve Reitmeister of Zen Investor, is also bullish on DLB — he recently named it his Stock of the Week. In a recent article, he explained why: 
• Management has ignited a turnaround after a few years of soft results. Part of this turnaround is expanding into new markets that use their audio software including voice conferencing and automobiles. Plus much of that recent growth has come from expansion into the video game market where the top releases often make more money than a top box office movie.
• The benefit of these new directions has led to some serious earnings acceleration which was quite evident in the 20.3% earnings beat from August 2024. This event sparked a nice round of outperformance for shares that continues into early 2025. 
• These investments in growth are fairly easy to do as the company has a large stockpile of almost $900 million in cash ($9.11 per share). And wouldn't be surprised if management has more growth ideas in store in the years ahead. 
• The Zen Ratings, with its full 115 factor analysis of every company, has most certainly tuned into the quality fundamentals of DLB. Not only is the stock an A overall, but actually in the top 3% of all stocks analyzed.
• There really is no weakness in DLB’s make up as you scan the 7 component grades, the lowest showing is still being in the top 29% for Momentum. No shame in that game. Where it really shines is the scores for Value, Safety and especially AI where it is in the top 3.6% of the 4,600 stocks reviewed by the quant model. (See all 7 Zen Component Grades here >)

What to Do Next?

• Watch “Zen Ratings Revolution” to Unlock +32.52% Annual Gains >
• Upgrade Your Investing - Start Your Premium Trial Now! >
• Discover Zen Investor portfolio to Find More 100%+ Stock Winners>

Want to get in touch? Email us at news@wallstreetzen.com.